Revelis Capital Group
Revelis Capital Group is a Denver-based venture firm affiliated with the Hopkinson family office, established in 2017. The firm specializes in investing in early to late-stage technology companies with significant growth potential. It focuses on providing primary and secondary capital investments ranging from $250,000 to $15 million, tailored to the specific capital needs of the companies and the liquidity preferences of their shareholders. Revelis Capital Group finances its investments on a deal-by-deal basis through internal resources and additional funding from a network of family offices, hedge funds, and high-net-worth individuals. This flexible approach allows the firm to curate investment products tailored to individual investor preferences. While it typically pools investments into structured vehicles for diversified exposure to the tech sector, it also has the capacity to execute independent investments when necessary.
TAP Network
Series A in 2020
TAP Network is a technology company focused on creating blockchain-powered software solutions for enterprise clients across various sectors, including entertainment, travel, and banking. It operates a Micro-Redemption Marketplace that features over 250,000 brands and merchants, allowing consumers to redeem loyalty points, cryptocurrencies, and real-world products and services for as little as $0.25. Co-founded by Lin Dai and Jared Christopherson, TAP Network aims to enhance consumer engagement and profitability for its enterprise partners by providing rewarding opportunities for everyday consumers. The company is recognized as a pioneer in decentralized advertising, leveraging its platform to facilitate discounts and cashback on transactions.
BioEclipse Therapeutics
Series A in 2019
BioEclipse Therapeutics is a clinical-stage biopharmaceutical company based in San Francisco, California, focused on developing curative immuno-oncology therapeutics for cancer patients. The company’s flagship product, CRX-100, represents a novel combination therapy that enhances the immune system's ability to combat cancer without the need to reengineer patients' cells. By utilizing a proprietary approach that combines activated immune cells with an adapted oncolytic virus, BioEclipse Therapeutics aims to selectively target and destroy malignant cells while improving tumor visibility to the immune system. The company's mission is to advance clinical outcomes and enhance the quality of life for cancer patients, with the ultimate goal of transforming cancer into a curable disease. BioEclipse Therapeutics was established in 2006 and was previously known as ConcentRx Inc before rebranding in 2017.
OnlySky
Seed Round in 2018
OnlySky offers a customizable cloud-based platform tailored for ski areas, enabling guests to create their ideal skiing experience directly on the ski area's website. The platform allows ski area staff to efficiently manage inventory, eCommerce, point-of-sale transactions, ski school operations, and events from a single interface. With no upfront fees and user-friendly design, it serves as an appealing solution for independent ski areas across North America and snow schools globally. By facilitating services such as equipment rentals and instructor bookings through mobile devices, OnlySky streamlines operations and enhances guest engagement, ultimately improving the overall skiing experience.
Hooch Inc. operates a subscription-based mobile application that provides members with access to cocktail drinks at participating bars in New York and Los Angeles. The app is available on both Android and iOS platforms, allowing users to enjoy exclusive offers and rewards. In addition to its bar offerings, Hooch also provides users with benefits such as cashback rewards of up to 10% when they travel, shop, or dine with its global partners. The company is headquartered in New York, New York.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.